Difference between revisions of "LncRNAWiki:A"
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| + | |||
| + | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
| + | Jump to section in alphabetical order : '''A''' [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
| + | </div> | ||
| + | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
| − | !Name | + | !width="50"|Name |
| − | !Transcript ID | + | !width="50"|Transcript ID |
| − | !Alias | + | !width="50"|Alias |
| − | !Description | + | !width="50"|Description |
| − | !Disease | + | !width="50"|Disease |
|- | |- | ||
|''21A'' | |''21A'' | ||
| Line 139: | Line 144: | ||
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8 | |human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8 | ||
|- | |- | ||
| + | |''ADAMTS9-AS1'' | ||
| + | |[[ADAMTS9-AS1]] | ||
| + | |N/A | ||
| + | |ADAMTS9 antisense RNA 1 | ||
| + | |epithelial ovarian cancer | ||
| + | |- | ||
| + | |''AFDN-AS1'' | ||
| + | |[[AFDN-AS1]] | ||
| + | |C6orf124, MLLT4-AS1, HGC6.4, dJ431P23.3 | ||
| + | |AFDN antisense RNA 1 (head to head) | ||
| + | |ovarian cancer | ||
| + | |- | ||
| + | |''ATP2C2-AS1'' | ||
| + | |[[ATP2C2-AS1]] | ||
| + | |RP11-517C16.2-001 | ||
| + | |ATP2C2 antisense RNA 1 | ||
| + | |Botulinum Toxin Type A | ||
| + | |- | ||
| + | |''ADGRD1-AS1'' | ||
| + | |[[ADGRD1-AS1]] | ||
| + | |LACAT8 | ||
| + | |ADGRD1 antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''ATP2B1-AS1'' | ||
| + | |[[ATP2B1-AS1]] | ||
| + | |N/A | ||
| + | |ATP2B1 antisense RNA 1 | ||
| + | |_ | ||
|} | |} | ||
Latest revision as of 12:34, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| 21A | NONHSAT128494 | ncRNA 21A | N/A | _ |
| 7SK | NONHSAT113149 | "7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198" | "RNA, 7SK small nuclear" | AIDS,cardiac hypertrophy,gastric cancer |
| 7SL | lnc-LRR1-1:1 | "7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486" | "RNA, 7SL, cytoplasmic 1" | AIDS,dermatomyositis |
| AATBC | AATBC | N/A | apoptosis associated transcript in bladder cancer | bladder cancer |
| ABALON | ABALON | INXS | apoptotic BCL2L1-antisense long non-coding RNA | tumor |
| ABHD11-AS1 | ABHD11-AS1 | NCRNA00035 | ABHD11 antisense RNA 1 (tail to tail) | gastric cancer |
| ABHD15-AS1 | ABHD15-AS1 | "linc-TP53I13, lnc-TP53I13" | ABHD15 antisense RNA 1 | cardiometabolic diseases |
| ACTA2-AS1 | ACTA2-AS1 | "uc001kfo.1, ZXF1" | ACTA2 antisense RNA 1 | lung adenocarcinoma |
| ADAMTS9-AS2 | ADAMTS9-AS2 | N/A | ADAMTS9 antisense RNA 2 | glioma |
| ADORA2A-AS1 | ADORA2A-AS1 | FLJ34651 | ADORA2A antisense RNA 1 | _ |
| AFAP1-AS1 | AFAP1-AS1 | MGC10981 | AFAP1 antisense RNA 1 | Barrett's esophagus and esophageal adenocarcinoma |
| AGAP2-AS1 | AGAP2-AS1 | "LOC100130776, PUNISHER" | AGAP2 antisense RNA 1 | _ |
| AIRN | ENST00000609176.1 | "AIR, IGF2RAS" | Antisense of IGF2R non-protein coding RNA | alcoholic liver disease,chronic nonalcoholic liver disease, hepatocelluar carcinoma |
| Alpha 250/Alpha 280 | NONHSAT104559,lnc-NDST1-1:2 | N/A | N/A | _ |
| ANP32A-IT1 | ANP32A-IT1 | "FLJ11722, HsT18971" | ANP32A intronic transcript 1 | _ |
| APOA1-AS | ENST00000444200.1 | APOA1 antisense RNA | N/A | _ |
| APTR | NONHSAT121673 | Alu-mediated CDKN1A/p21 | N/A | liver cirrhosis |
| ARRDC1-AS1 | ARRDC1-AS1 | N/A | ARRDC1 antisense RNA 1 | breast cancer |
| ASAP1-IT1 | ASAP1-IT1 | "HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT" | ASAP1 intronic transcript 1 | _ |
| ASMTL-AS1 | ASMTL-AS1 | FLJ13330 | ASMTL antisense RNA 1 | _ |
| ATP1A1-AS1 | ATP1A1-AS1 | MGC16179 | ATP1A1 antisense RNA 1 | _ |
| ATXN8OS | NONHSAT034251 | "NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223" | Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand | human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8 |
| ADAMTS9-AS1 | ADAMTS9-AS1 | N/A | ADAMTS9 antisense RNA 1 | epithelial ovarian cancer |
| AFDN-AS1 | AFDN-AS1 | C6orf124, MLLT4-AS1, HGC6.4, dJ431P23.3 | AFDN antisense RNA 1 (head to head) | ovarian cancer |
| ATP2C2-AS1 | ATP2C2-AS1 | RP11-517C16.2-001 | ATP2C2 antisense RNA 1 | Botulinum Toxin Type A |
| ADGRD1-AS1 | ADGRD1-AS1 | LACAT8 | ADGRD1 antisense RNA 1 | _ |
| ATP2B1-AS1 | ATP2B1-AS1 | N/A | ATP2B1 antisense RNA 1 | _ |
